Mode
Text Size
Log in / Sign up
Phase 4 Completed N=224 Randomized Triple-blind Treatment

Treatment of Bipolar Mania in Older Adults

Source: ClinicalTrials.gov NCT00254488 ↗
Enrolled (actual)
224
Serious AEs
20.5%
Results posted
Aug 2018
Primary outcomePrimary: Sedation Score — 0.5; 0.5; 0.6; 0.6 units on a scale
◆ Published Evidence
Established
37citations · ~2 / year
Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.
Bipolar disorders · 2010 · Open access · High-confidence link

Summary

This study will compare the benefits and side effects of lithium and divalproex in the treatment of older adults with bipolar mania.

Linked Publications (5)

  • Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.
    Bipolar disorders · 2010 · 37 citations · Open access · High-confidence link
  • The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults.
    Bipolar disorders · 2010 · 34 citations · Open access · High-confidence link
  • Characteristics associated with inpatient versus outpatient status in older adults with bipolar disorder.
    Journal of geriatric psychiatry and neurology · 2012 · 18 citations · Open access · High-confidence link
  • Social support in late life mania: GERI-BD.
    International journal of geriatric psychiatry · 2014 · 12 citations · Open access · High-confidence link
  • Depression symptom ratings in geriatric patients with bipolar mania.
    International journal of geriatric psychiatry · 2011 · 12 citations · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Sedation Score
0.5; 0.5; 0.6; 0.6; 0.4; 0.5
PRIMARY
Young Mania Rating Scale (YMRS) Scores
21.4; 19.7; 19.0; 16.3; 14.3; 15.2

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of DSM-IV Bipolar Disorder, Type I: current manic, mixed, or hypomanic episodes

Exclusion Criteria

  • Rapid cycling bipolar disorder
  • History of substance abuse or dependence within last 3 months
  • Diagnosis of schizophrenia or other chronic psychotic conditions
  • Acute or unstable medical illness
  • Documented intolerance to Lithium, Depakote, Risperidone, or Lorazepam
  • Dementia
  • Inability to communicate in English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00254488) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search